Benzinga | Sep 22, 2021 12:50PM EDT

UPDATE: Boston Scientific Sees FY21 Durable Organic Sales Growth 19-20%, Adj. EPS $1.58-$1.62 vs $1.61 Estimate

https://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR-V3/documents/events/BSX-Investor-Day-2021-22Sep-final-final.pdf